Synmosa Biopharma Corp
TPEX:4114
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Synmosa Biopharma Corp
TPEX:4114
|
TW |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Synmosa Biopharma Corp's stock price target?
Not Available
Synmosa Biopharma Corp does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Synmosa Biopharma Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 1 year is 13%.
What is the Gross Profit forecast for Synmosa Biopharma Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 1 year is 14%.
What is the Operating Income forecast for Synmosa Biopharma Corp?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Operating Income has been 39%. The projected CAGR for the next 1 year is 19%.
What is the Pre-Tax Income forecast for Synmosa Biopharma Corp?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 1 year is 17%.
What is the Net Income forecast for Synmosa Biopharma Corp?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 1 year is 16%.
